Paul Gavin

Avecho Biotechnology’s Japanese patent adds another major jurisdiction to the intellectual property estate surrounding its TPM-enhanced cannabidiol capsule. The grant strengthens the company’s negotiating position, but clinical completion, regulatory approval and regional licensing remain the decisive commercial tests.